Zealand Pharma A/S (CPH:ZEAL)

Zealand Pharma Revenue

Zealand Pharma had revenue of 4.49B DKK in the quarter ending June 30, 2026, a decrease of -50.58%. This brings the company's revenue in the last twelve months to 4.64B, down -49.03% year-over-year. In the year 2025, Zealand Pharma had annual revenue of 9.21B with 14,598.86% growth. That makes Zealand Pharma the 9,356th largest company in the world by revenue and 42nd in Denmark.

• Revenue (ttm): 4.64B
• Revenue Growth: -49.03%
• P/S Ratio: 3.49
• Revenue / Employee: 8.03M
• Employees: 578
• Market Cap: 16.21B

Revenue Chart

Chart

Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	9.21B	9.15B	14,598.86%
Dec 31, 2024	62.69M	-280.10M	-81.71%
Dec 31, 2023	342.79M	238.80M	229.65%
Dec 31, 2022	103.99M	-4.56M	-4.20%
Dec 31, 2021	108.55M	-83.46M	-43.47%
Dec 31, 2020	192.00M	150.67M	364.52%
Dec 31, 2019	41.33M	3.36M	8.84%
Dec 31, 2018	37.98M	-98.35M	-72.14%
Dec 31, 2017	136.32M	-94.54M	-40.95%
Dec 31, 2016	230.86M	43.19M	23.01%
Dec 31, 2015	187.68M	33.90M	22.05%
Dec 31, 2014	153.77M	147.20M	2,239.11%
Dec 31, 2013	6.57M	-216.99M	-97.06%
Dec 31, 2012	223.57M	81.28M	57.13%
Dec 31, 2011	142.28M	54.93M	62.88%
Dec 31, 2010	87.36M	62.04M	245.03%
Dec 31, 2009	25.32M	-	-

Data Source: Fiscal.ai Last updated: Aug 13, 2026

Revenue data is provided by Fiscal.ai and updates within minutes after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Oct 9, 2026

Data Sources Report a data error